C4orf3 | Chromosome 4 open reading frame 3 | Predicted membrane proteins
| | | | | Expressed in all |
C7orf26 | Chromosome 7 open reading frame 26 | | | | | | Expressed in all |
C8orf58 | Chromosome 8 open reading frame 58 | | | | | | Expressed in all |
CA14 | Carbonic anhydrase XIV | Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CALD1 | Caldesmon 1 | Cytoskeleton related proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CANX | Calnexin | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CAPN1 | Calpain 1, (mu/I) large subunit | Enzymes Plasma proteins
| | | | | Expressed in all |
CAPN2 | Calpain 2, (m/II) large subunit | Enzymes Plasma proteins
| | | | | Expressed in all |
CASK | Calcium/calmodulin-dependent serine protein kinase (MAGUK family) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CAV2 | Caveolin 2 | Predicted membrane proteins
| | | | | Mixed |
CBR1 | Carbonyl reductase 1 | Enzymes Plasma proteins
| | | | | Expressed in all |
CBR3 | Carbonyl reductase 3 | Enzymes
| | | | | Mixed |
CBS | Cystathionine-beta-synthase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
CCDC104 | Coiled-coil domain containing 104 | | | | | | Expressed in all |
CCDC47 | Coiled-coil domain containing 47 | Predicted membrane proteins
| | | | | Expressed in all |
CCNA2 | Cyclin A2 | Cancer-related genes
| | | | | Mixed |
CCNB1 | Cyclin B1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CCNC | Cyclin C | | | | | | Expressed in all |
CCND1 | Cyclin D1 | Cancer-related genes Disease related genes FDA approved drug targets
| | | | | Mixed |
CCND3 | Cyclin D3 | Cancer-related genes
| | | | | Expressed in all |
CCNI | Cyclin I | | | | | | Expressed in all |
CCNL2 | Cyclin L2 | Predicted secreted proteins
| | | | | Expressed in all |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CCT7 | Chaperonin containing TCP1, subunit 7 (eta) | Plasma proteins
| | | | | Expressed in all |
CD151 | CD151 molecule (Raph blood group) | Blood group antigen proteins CD markers Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
CD164 | CD164 molecule, sialomucin | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD247 | CD247 molecule | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
CD27 | CD27 molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CD276 | CD276 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CD300C | CD300c molecule | CD markers Predicted membrane proteins
| | | | | Mixed |
CD33 | CD33 molecule | CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Mixed |
CD34 | CD34 molecule | CD markers Predicted membrane proteins
| | | | | Expressed in all |
CD37 | CD37 molecule | CD markers Predicted membrane proteins
| | | | | Expressed in all |
CD3E | CD3e molecule, epsilon (CD3-TCR complex) | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
CD44 | CD44 molecule (Indian blood group) | Blood group antigen proteins Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD48 | CD48 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD59 | CD59 molecule, complement regulatory protein | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD6 | CD6 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD63 | CD63 molecule | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CD68 | CD68 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD69 | CD69 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
CD82 | CD82 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CD86 | CD86 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CD9 | CD9 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CD93 | CD93 molecule | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CD97 | CD97 molecule | CD markers G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
CD99 | CD99 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CDC34 | Cell division cycle 34 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Expressed in all |